FIGURE

Figure 1.

ID

ZDB-FIG-221030-17

Publication

Wang et al., 2022 - Hoxa9/meis1-transgenic zebrafish develops acute myeloid leukaemia-like disease with rapid onset and high penetrance

Other Figures

All Figure Page

Back to All Figure Page

Figure 1.

Transgenic zebrafish express hoxa9 under the control of drl regulatory element. (a) The schematic representation of Tg(drl:hoxa9) expression with ∂-crystallin::Venus GFP reporter gene. A GFP variant is expressed in the eyes under the control of the ∂-crystallin lens promoter (white arrowheads). Whole-mount immunofluorescence staining with anti-myc antibody indicated the overexpression of hoxa9 in blood cells (white arrows). (b) WISH assay for HSC gene, runx1 in embryos at 36 hpf-3 dpf. (c) WISH for myeloid progenitor gene, c-myb in embryos at 36 hpf-5 dpf. (d) WISH for neutrophil gene, mpx in embryos at 3–5 dpf. (e) WISH for macrophage gene, mfap4 in embryos 3–5 dpf. (f) WISH for erythroid gene, hbbe1 in embryos 3 dpf. (g) Quantification of WISH results in (b–f) at 36 hpf-5 dpf (n = 50–200 embryos per group). Data are represented as mean ± s.d. *p < .05, **p < .01, ***p < .001. drl, draculin; FLM, fluorescence microscopy; WISH, whole-mount in situ hybridization; hpf, hours post-fertilization; dpf, days post-fertilization.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Open Biol.